Analysis of particle size and morphology provides essential information for formulators developing thixotropic suspensions.
Confirming particle size and ensuring that suspended drug particles are evenly dispersed within a
thixotropic solution creates a number of challenges. This article will discuss the issues that formulators have to address when creating a thixotrophic suspension and the types of analyses that are available to determine the extent to which the nasal spray has been optimized.